NCT07904468
Daily Cognitive Failures and Medication Adherence in Fibromyalgia
StatusNot Yet Recruiting
PhaseNot specified
SponsorMardin Artuklu University
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Medication Adherence Assessed by MARS-5 in Relation to Pain Severity
Timeframe: Baseline
Secondary (2)
Everyday Cognitive Failures Assessed by the Cognitive Failures Questionnaire (CFQ)
Anxiety Symptoms Assessed by the Hospital Anxiety and Depression Scale (HADS-A)
Arms and interventions
Fibromyalgia Group
Adults aged 18-65 years diagnosed with fibromyalgia according to the 2016 American College of Rheumatology (ACR) criteria and regularly taking at least one medication for fibromyalgia. Participants will undergo a single-visit assessment using the Cognitive Failures Questionnaire (CFQ), Medication Adherence Report Scale (MARS-5), and Hospital Anxiety and Depression Scale (HADS). Demographic characteristics, pain severity, and medication use will also be recorded. No experimental interventions or additional medical procedures will be performed.
Sites
1 site in 1 country
- Mardin Training and Research HospitalMardin, Turkey (Türkiye)